Novel Extender Units for Polyketide Synthase Diversity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The limited number of known Type I polyketide synthase extender units restricts the structural diversity of polyketides, making it challenging to generate new derivatives with enhanced biological activities and reduced side effects, as existing units lack chemical attributes for downstream modification.
Innovation Solution
The identification and synthesis of novel extender units such as hydroxymalonyl-ACP (HM-ACP) and aminomalonyl-ACP (AM-ACP) are achieved through the discovery of specific enzymes responsible for their biosynthesis, enabling their incorporation into polyketide molecules, which introduces new chemical attributes and reactivity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If traditional extender units (malonyl-CoA, methylmalonyl-CoA, ethylmalonyl-CoA, and methoxymalonyl-ACP) are used in Type I PKS, then polyketide backbone assembly is achieved, but structural diversity is limited due to similar chemical attributes and lack of downstream modification capability
Solution Approach 1:
The patent changes the chemical parameters of extender units by introducing hydroxyl and amino groups at specific positions (alpha or beta carbons) of the malonyl-CoA backbone. This creates novel extender units (hydroxymalonyl-CoA, aminomalonyl-CoA) with different chemical attributes that enable downstream modification while maintaining compatibility with Type I PKS machinery
Solution Approach 2:
The patent demonstrates that a single Type I PKS can incorporate multiple different extender unit types (malonyl-CoA, methylmalonyl-CoA, ethylmalonyl-CoA, methoxymalonyl-ACP, and the newly discovered hydroxymalonyl-CoA and aminomalonyl-CoA) through its modular architecture, allowing one system to produce diverse polyketide structures
2Productivity
If synthetic or semisynthetic chemistry is used to modify known polyketides, then new derivatives can be generated, but efficiency decreases as polyketide structure complexity increases
Solution Approach 1:
The patent introduces functional groups (hydroxyl and amino groups) into the polyketide backbone during the biosynthetic assembly process itself, rather than requiring post-synthesis chemical modification. This preliminary introduction of reactive groups enables easier downstream modification while maintaining high efficiency even for complex structures
3Adaptability or versatility
If metabolic engineering of polyketide biosynthetic pathway is used, then new structural derivatives can be generated, but the number of incorporable precursors is limited
Solution Approach 1:
The patent changes the chemical parameters of available precursors by introducing hydroxyl and amino functional groups onto malonyl-CoA and related extender units. This creates new precursor types that can be incorporated into polyketide backbones, expanding the metabolic engineering toolbox while maintaining compatibility with existing PKS modules
Solution Approach 2:
The patent discovers that endogenous enzymes within the bacterial cell can naturally produce hydroxymalonyl-CoA and aminomalonyl-CoA from standard metabolic intermediates, allowing the system to self-generate novel extender units without requiring external supplementation or complex engineered pathways
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly expands the metabolic engineering potential of Type I polyketide synthases, allowing for the introduction of hydroxyl or amino group functionality into polyketide backbones, thereby increasing structural diversity and potential biological activities of polyketide products.
Implementation Method 1
The polypeptides have phosphatase and acyltransferase activity. The polypeptides are involved in converting 1,3-bisphosphoglycerate to glyceryl-acyl carrier protein.
Implementation Method 2
The polypeptides have phosphatase and acyltransferase activity. The polypeptides are involved in converting 1,3-bisphosphoglycerate to glyceryl-acyl carrier protein.
Implementation Method 3
Polyketides are a class of compounds synthesized by the enzymatic polymerization of acetyl, proprionyl, butyryl and methoxyacetyl moieties (extender units) into a polyketide backbone through a series of decarboxylative condensation and reduction reactions
Implementation Method 4
Polyketides are a class of compounds synthesized by the enzymatic polymerization of acetyl, proprionyl, butyryl and methoxyacetyl moieties (extender units) into a polyketide backbone through a series of decarboxylative condensation and reduction reactions
Data Source
AI summary
Novel extender units for Type I polyketide synthases are provided. Also provided are genes, compounds, and methods for generating these units, and for incorporation of the novel extender units into polyketides for the purpose of generating new structural derivatives of polyketide-containing products.